Ask AI

Translating Progress Into Practice: Optimizing MS Treatment and Patient Outcomes

Review this program about the immunopathogenic mechanisms and biologic basis of multiple sclerosis (MS) in the context of available treatment options; evaluating clinical trial data on approved and emerging disease-modifying therapies for relapsing MS; applying efficacy, safety, and disease activity metrics to tailor treatment selection and monitoring plans for relapsing MS; and incorporating evidence-based communication techniques and multidisciplinary care approaches to support shared decision-making, improve adherence, and optimize long-term outcomes in MS management.

Share

Program Content

Activities

Optimizing Multiple Sclerosis Treatment
Translating Progress Into Practice: Optimizing MS Treatment and Patient Outcomes
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: January 12, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Novartis Pharmaceuticals Corporation